These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5053584)

  • 41. Potentiation of the antitumor effect of 5-fluorouracil by some nucleotides, and their possible role in the potentiation.
    Tezuka M; Tamemasa O
    Jpn J Exp Med; 1983 Jun; 53(3):155-63. PubMed ID: 6663806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    Ingraham HA; Tseng BY; Goulian M
    Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorus incorporation in the Ehrlich ascites tumor cell.
    Levinson C; Gordon ED
    J Cell Physiol; 1971 Oct; 78(2):257-64. PubMed ID: 5156707
    [No Abstract]   [Full Text] [Related]  

  • 44. Nucleoside antibiotics. I. Biochemical tools for studying the structural requirements for interaction at the catalytic and regulatory sites of ribonucleotide reductase from Lactobacillus leichmannii.
    Suhadolnik RJ; Finkel SI; Chassy BM
    J Biol Chem; 1968 Jun; 243(12):3552-7. PubMed ID: 5656392
    [No Abstract]   [Full Text] [Related]  

  • 45. Enzymic synthesis of uridine diphosphoglucose-14-C.
    Fitzgerald DK; Ebner KE
    Anal Biochem; 1966 Apr; 15(1):150-3. PubMed ID: 5959418
    [No Abstract]   [Full Text] [Related]  

  • 46. A convenient assay for ADP reductase activity using Dowex-1-borate columns.
    Cory JG; Russell FA; Mansell MM
    Anal Biochem; 1973 Oct; 55(2):449-56. PubMed ID: 4543028
    [No Abstract]   [Full Text] [Related]  

  • 47. Antimitotic action of 5-(2'-bromo-acetamido)-uracil on the Ehrlich ascites tumor.
    OKADA TA; ROBERTS E
    Proc Soc Exp Biol Med; 1962 Dec; 111():695-8. PubMed ID: 13939762
    [No Abstract]   [Full Text] [Related]  

  • 48. Fluorinated pyrimidines and their nucleosides.
    Heidelberger C; Danenberg PV; Moran RG
    Adv Enzymol Relat Areas Mol Biol; 1983; 54():58-119. PubMed ID: 6189380
    [No Abstract]   [Full Text] [Related]  

  • 49. Prebiotic phosphorylation-nucleotide synthesis with apatite.
    Schwartz AW
    Biochim Biophys Acta; 1972 Nov; 281(4):477-80. PubMed ID: 4569283
    [No Abstract]   [Full Text] [Related]  

  • 50. The formation of uridine diphosphate-2-deoxy-D-glucose in yeast.
    Biely P; Bauer S
    Biochim Biophys Acta; 1966 May; 121(1):213-4. PubMed ID: 5956946
    [No Abstract]   [Full Text] [Related]  

  • 51. Synthesis and degradation fo UDP-glucuronic acid in the hyalocytes of calf vitreous.
    Jacobson B
    Exp Eye Res; 1967 Oct; 6(4):332-5. PubMed ID: 6060544
    [No Abstract]   [Full Text] [Related]  

  • 52. Promotion of purine nucleotide binding to thymidylate synthase by a potent folate analogue inhibitor, 1843U89.
    Weichsel A; Montfort WR; Cieśla J; Maley F
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3493-7. PubMed ID: 7724588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemical and genetic basis of the response to 5-fluorouracil in Drosophila melanogaster.
    O'Byrne-Ring N; Duke E
    Biochem Genet; 1980 Aug; 18(7-8):717-26. PubMed ID: 6451215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
    Roobol C; De Dobbeleer GB; Bernheim JL
    Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.
    Maehara Y; Sakaguchi Y; Takahashi I; Yoshida M; Kusumoto H; Masuda H; Sugimachi K
    Cancer Chemother Pharmacol; 1992; 29(4):257-60. PubMed ID: 1537070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of single-agent therapy in human colorectal tumour xenografts.
    Houghton PJ; Houghton JA
    Br J Cancer; 1978 May; 37(5):833-40. PubMed ID: 656310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.
    Sadee W; Wong CG
    Clin Pharmacokinet; 1977; 2(6):437-50. PubMed ID: 589882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of 5-fluorouracil on the cell kinetic and growth parameters of hepatoma 3924A.
    Kovacs CJ; Hopkins HA; Simon RM; Looney WB
    Br J Cancer; 1975 Jul; 32(1):42-50. PubMed ID: 169869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antineoplastic drugs: clinical pharmacology and therapeutic use.
    Bender RA; Zwelling LA; Doroshow JH; Locker GY; Hande KR; Murinson DS; Cohen M; Myers CE; Chabner BA
    Drugs; 1978 Jul; 16(1):46-87. PubMed ID: 78795
    [No Abstract]   [Full Text] [Related]  

  • 60. Fluorinated pyrimidines. XL. The reduction of 5-fluorouridine 5'-diphosphate by ribonucleotide reductase.
    Kent RJ; Heidelberger C
    Mol Pharmacol; 1972 Jul; 8(4):465-75. PubMed ID: 5053584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.